Other news

u-card-img-1
News
Publication in NANOLetters

Nanobiophysical approach offers new perspectives for oncolytic cancer therapy

David Alsteens (WELBIO - UCLouvain) and his team demonstrate the role of α-sialylated glycans in enhancing oncolytic therapy in breast cancer using atomic force microscopy.

Learn more
u-card-img-1
News
European Association for Cancer Research (EACR) Prize

EACR’s Mike Gold Medal Award 2022 to Cédric Blanpain

Cédric Blanpain (WELBIO - ULB) is the 2022 winner of the EACR’s Mike Price Gold Medal, which rewards a senior researcher who has made an outstanding contribution to the progress of cancer research in Europe.

Learn more
u-card-img-1
News
Publication in Oncogene

A dual role for COP1 in breast cancer

Alain Chariot (WELBIO – ULiège) and his team demonstrated that COP1 can act as an oncogenic E3 ligase by promoting ERa signaling but also as a tumor suppressor candidate by preventing epithelial-mesenchymal transition.

Learn more
u-card-img-1
News
Spin-off creation

Santero Therapeutics: Towards a new generation of antibiotics

From fundamental research on bacterial metabolism in Abel Garcia-Pino's laboratory (WELBIO - ULB) to the development of a new generation of antibiotics.

Learn more
u-card-img-1
News
Queen Elisabeth Medical Foundation Prize 2020

Ernest Solvay Prize to Benoît Vanhollebeke

The Ernest Solvay 2020 Prize of the Queen Elisabeth Medical Foundation was awarded to Benoît Vanhollebeke (WELBIO - ULB) at a ceremony attended by Her Majesty the Queen.

Learn more
u-card-img-1
News

Launch of the 2021 WELBIO Investigator Programme call!

The FRFS-WELBIO announces its 2021 call for "WELBIO Investigator programmes" for basic research in the fields of life sciences that can lead to applications in all fields of (bio)technology.

Learn more
u-card-img-1
News
Prix Quinquennaux FNRS 2020

Prix scientifique Joseph Maisin à Jean-François Collet

Le Prix Joseph Maisin en Sciences biomédicales fondamentales 2020 a été attribué à Jean-François Collet (WELBIO - UCLouvain) lors d’une cérémonie en présence de Sa Majesté le Roi.

Learn more
u-card-img-1
News
Publication in Molecular Cell

A magic alarmone to rescue hungry bacteria

Abel Garcia-Pino (WELBIO – ULB) and his team shed light on the role played by  alarmone for induction of the synthetic activity of E. coli RelA by starved ribosomes.

Learn more
u-card-img-1
News
Publication in Molecular Cell

An old fold can learn new tricks

Abel Garcia-Pino (WELBIO – ULB) and his team uncovered the mechanism of toxicity used by the toxin-antitoxin systems (toxSAS) in bacteria.

Learn more
u-card-img-1
News

2020 Annual report

2020 marks the 10th anniversary of our first call for projects! Learn about our researchers, their scientific advances and how some of their discoveries have been translated into applications for human health.

Learn more
u-card-img-1
News
Publication in Nature Cancer

RNA epigenetics as a key regulator of cancer metastasis

François Fuks (WELBIO – ULB) and his team demonstrated the role of the regulation of RNA epigenetics by the FTO enzyme in the development of cancer metastasis.

Learn more
u-card-img-1
News
Spin-off creation

NeuVasQ: An innovative approach to fight against neurovascular and neurodegenerative diseases

From disruptive research of scientific founder Benoit Vanhollebeke (WELBIO - ULB) to the development of blood-brain barrier pharmaceuticals aiming at repairing neurovascular function and neurodegenerative diseases.

Learn more

Share this page